MedTrainer's Healthcare Course Library

The Sofia RSV FIA employs immunofluorescence for detection of respiratory syncytial virus (RSV) nucleoprotein antigen in nasopharyngeal swab and nasopharyngeal aspirate/wash specimens taken directly from symptomatic patients. This course covers when and how to use the Sofia RSV, general operations, and how to collect a sample.

The BiliChek System is a non-invasive tool used to measure bilirubin levels in infants to check for hyperbilirubinemia. This course covers when and how to use the BiliChek System, general operations, and how to collect a sample.

Providing lab accuracy and ease of use, the HemoCue 201+ System has become a standard in hemoglobin point-of-care testing. This course covers when and how to use the Hemocue 201 Hgb, general operations, and how to collect a sample.

Welcome to the OSOM Trichomonas Rapid Test course. The OSOM Trichomonas Test is used to detect Trichomonas Vaginali, which is the most common, non-viral sexually transmitted disease around the world. This course covers general operations, routine use, sample collection as well as equipment maintenance and QC.

The TRUE METRIX portfolio achieves a level of performance driven by science, research and technological advancements. Featuring TRIPLE SENSE TECHNOLOGY, the system provides clinically proven accuracy and confidence in results.

Proper specimen handling is a critical component in ensuring integrity of specimen samples as well as coinciding accurate test results in the laboratory. The handling of specimens also represents a significant safety risk for all laboratory personnel involved. In order to achieve accurate test results and to minimize the safety risk, strict adherence to the applicable regulations, requirements, policies, and procedures is imperative in a laboratory. In this course, we will discuss the foundational requirements for the safe and proper handling of specimens according to OSHA and CLIA standards, as well as how organizations and laboratories have expanded upon these requirements with recommendations on specimen handling.

All laboratory facilities in the United States that perform testing on human specimens for health assessments or the diagnosis, prevention, or treatment of diseases fall under the guidance and regulatory requirements of the Clinical Laboratory Improvement Amendments of 1988 (CLIA). Under CLIA, low-risk tests can be waived and performed with no routine regulatory oversight in physicians offices and various other locations. These waived tests include a test system, assay, or examination cleared by the Federal Drug Administration (FDA) for home use or Health and Human Services (HHS) that meets the CLIA criteria of being a simple test with an insignificant risk for an erroneous result.
These CLIA regulations require a facility to appropriately certify each waived test performed. The latest tests approved by the FDA as waived tests under CLIA can be found in the appropriately-dated versions of the Centers for Medicare and Medicaid Services (CMS) Online Manual System, New Waived Tests Transmittal, Recurring Update Notification attachments. Effective dates and descriptions are provided in these notifications for each of the latest FDA approved tests (e.g., 87502QW, May 28, 2019, Alere ID NOW Instrument {Nasal and Nasopharyngeal swabs}, for Influenza A/B). Each CLIA-approved facility recognizes that the associated Current Procedural Terminology (CPT) codes (e.g., 87502QW) indicate which newly FDA-approved tests meet waived test criteria. The Healthcare Common Procedure Coding System (HCPCS) has its own guidelines and is based on these American Medical Association CPT codes.
In this course, we cover the purpose for Recurring Update Notifications of waived tests, CPT codes for waived tests associated with these Recurring Update Notifications, and current Recurring Update Notifications for Influenza, Strep, Mono, and HCG (urine vs. serum), etc.

All laboratory facilities in the United States that perform testing on human specimens for health assessments or the diagnosis, prevention, or treatment of diseases fall under the guidance and regulatory requirements of the Clinical Laboratory Improvement Amendments of 1988 (CLIA). Under CLIA, low-risk tests can be waived and performed with no routine regulatory oversight in physicians offices and various other locations. These waived tests include a test system, assay, or examination cleared by the Federal Drug Administration (FDA) for home use or Health and Human Services (HHS) that meets the CLIA criteria of being a simple test with an insignificant risk for an erroneous result.
Clinical laboratories that conduct only waived testing are required to have a valid Certificate of Waiver (COW) from CLIA. For clinical laboratories to qualify for this CLIA COW, they must only perform waived tests as defined by CLIA. As part of compliance investigations, these laboratories are inspected to ensure that they are indeed performing only waived testing. Human Health Services will limit, suspend, or revoke a laboratorys Certificate of Waiver for failing to comply with State Operations Manual requirements. In this course, we cover waived testing as outlined by CLIA, the requirements for laboratories to qualify for a CLIA Certificate of Waiver (COW), and the CLIA COW application process for first-time waived testers.

Phlebotomy is the act of making a puncture in a vein in order to draw blood. This procedure is exceptionally common in health care and medical research. Great care and precision must be practiced in order to limit and reduce any injuries and errors to the patient and the blood sample. This course will cover the types of errors and injuries that may occur in phlebotomy, as well as tips and best practices recommended by the World Health Organization to reduce these errors and injuries.